Physician profile
Manrique Alberto Guerrero
NPI 1780055889
$16,002.74
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $2,775 · 2023: $421 · 2024: $1,269 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $2,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Food and Beverage | $2,413.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,004.40 | 2025 | |
| Zimmer Biomet Holdings, INC. | $2,745.65 | 2021-2023 | Advantagerib, Ribfix Blu Advantage |
| Acera Surgical, INC. | $1,449.62 | 2022-2025 | Restrata Wound Matrix |
| Atricure, INC. | $701.79 | 2022-2024 | |
| Integra Lifesciences Corporation | $388.82 | 2021 | |
| Polynovo North America LLC | $255.66 | 2024-2025 | Novosorb Btm |
| Biotissue Holdings INC. | $184.87 | 2022 | |
| Davol INC. | $101.66 | 2022 | |
| Baxter Healthcare | $56.93 | 2024-2025 | Floseal, Artiss |
| Avita Medical Americas, LLC | $51.92 | 2021 | |
| Boston Scientific Corporation | $41.87 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Kerecis Limited | $19.55 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manrique Guerrero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.